You are here

generics

House Committee Quizzes FDA on Complex Generic Drugs

House Committee Quizzes FDA on Complex Generic Drugs

RAPS.org

Flag link:

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

NPR

multiple sclerosis

Flag link:

Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products

Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products

Motley Fool

Flag link:

California plans to launch own prescription drug label

California plans to launch own prescription drug label

The Hill

Flag link:

Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst

Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst

Fierce Pharma

Flag link:

FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports

FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports

RAPS.org

Flag link:

Lilly claims another victory in Alimta patent defence

Lilly claims another victory in Alimta patent defence

Pharmaforum

Flag link:

As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis

As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis

Endpoints

Bristol-Myers Squibb

Flag link:

Glenmark Zantac generic recall comes as Congresswoman assails FDA for inaction

Glenmark Zantac generic recall comes as Congresswoman assails FDA for inaction

Fierce Pharma

Flag link:

82 Professors Call on Court to Support FTC Decision in Pay-for-Delay Case

82 Professors Call on Court to Support FTC Decision in Pay-for-Delay Case

RAPS.org

Endo Pharmaceuticals

Flag link:

Amneal to buy generic pharmaceuticals provider AvKARE for $340m

Amneal to buy generic pharmaceuticals provider AvKARE for $340m

Pharmaceutical Business Review

Flag link:

Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?

Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?

FDA Law Blog

Hatch Waxman Act

Flag link:

Prescription Drug Prices Dip Slightly in the U.S., the First Time in 45 Years

Prescription Drug Prices Dip Slightly in the U.S., the First Time in 45 Years

BioSpace

Flag link:

While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats

While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats

Endpoints

multiple sclerosis

Torrent Pharmaceuticals

Flag link:

After Zantac scare, FDA targets generic metformin for carcinogen tests

After Zantac scare, FDA targets generic metformin for carcinogen tests

Fierce Pharma

type 2 diabetes

Flag link:

DOJ inks price fixing settlement with small generics player. Will others follow?

DOJ inks price fixing settlement with small generics player. Will others follow?

Fierce Pharma

Rising Pharmaceuticals

Flag link:

Chasing Mylan, Hikma tries again with rejected generic Advair in US

Chasing Mylan, Hikma tries again with rejected generic Advair in US

Pharmaforum

Flag link:

Teva, others talk settlements with feds in yearslong generics price fixing probe: report

Teva, others talk settlements with feds in yearslong generics price fixing probe: report

Fierce Pharma

Teva Pharmaceutical

Taro Pharmaceuticals

Flag link:

FDA releases 81 product-specific guidances

FDA releases 81 product-specific guidances

Endpoints

Flag link:

Despite Record Number of Generic Drug Approvals, Many Are Not Yet Available in the U.S.

Despite Record Number of Generic Drug Approvals, Many Are Not Yet Available in the U.S.

BioSpace

Flag link:

Pages